One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Heart failure in cardio-oncology and adult congenital heart disease: new challenges and therapeutic targets
Filippo Crea
doi : 10.1093/eurheartj/ehac621
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4443–4446
From the garden to the clinic: how Mendelian randomization is shaping up atherosclerotic cardiovascular disease prevention strategiesÂ
Benoit J Arsenault
doi : 10.1093/eurheartj/ehac394
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4447–4449
CureHeart wins Big Beat Challenge, a £30 million research award from the British Heart FoundationÂ
Metin Avkiran
doi : 10.1093/eurheartj/ehac510
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4450–4452
Bioelectronic medicine and its applications in cardiologyÂ
Alberto Giannoni, Francesco Gentile, Claudio Passino
doi : 10.1093/eurheartj/ehac343
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4453–4455
Antiplatelet therapy to prevent graft failure after coronary artery bypass graft: aspirin monotherapy for most, DAPT for selected fewÂ
Rocco Vergallo, Carlo Patrono
doi : 10.1093/eurheartj/ehac503
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4456–4457
Cardiovascular complications of immune checkpoint inhibitors for cancerÂ
Franck Thuny, Jarushka Naidoo, Tomas G Neilan
doi : 10.1093/eurheartj/ehac456
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4458–4468,
Over the last decade or so, there has been a paradigm shift in the oncologic care of patients with a range of solid tumour and haematologic malignancies, away from traditional cytotoxic chemotherapy and towards personalized cancer treatments, using both targeted therapy and immunotherapy.
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillationÂ
Toru Kondo, Azmil H Abdul-Rahim, Atefeh Talebi, William T Abraham, Akshay S Desai, Kenneth Dickstein, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Milton Packer, Mark Petrie, Piotr Ponikowski, Jean L Rouleau, Marc S Sabatine, Karl Swedberg, Michael R Zile, Scott D Solomon, Pardeep S Jhund, John J V McMurray
doi : 10.1093/eurheartj/ehac487
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4469–4479
Patients with heart failure with reduced ejection fraction (HFrEF) are at significant risk of stroke. Anticoagulation reduces this risk in patients with and without atrial fibrillation (AF), but the risk-to-benefit balance in the latter group, overall, is not favourable.
Stroke risk stratification in patients with heart failure and sinus rhythmÂ
Dimitrios Sagris, Eduard Shantsila, Gregory Y H Lip
doi : 10.1093/eurheartj/ehac493
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4480–4482
Last year of life of adults with congenital heart diseases: causes of death and patterns of careÂ
Liesbet Van Bulck, Eva Goossens, Lucas Morin, Koen Luyckx, Fouke Ombelet, Ruben Willems, Werner Budts, Katya De Groote, Julie De Backer, Lieven Annemans, Stéphane Moniotte, Michèle de Hosson, Arianne Marelli, Philip Moons, BELCODAC consortium
doi : 10.1093/eurheartj/ehac484
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4483–4492
Although life expectancy in adults with congenital heart diseases (CHD) has increased dramatically over the past five decades, still a substantial number of patients dies prematurely.
A view from the end: what the last year of life can teach us about palliative care on the adult congenital heart disease journeyÂ
Jill M Steiner, James N Kirkpatrick
doi : 10.1093/eurheartj/ehac492
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4493–4495
A circular RNA derived from the insulin receptor locus protects against doxorubicin-induced cardiotoxicityÂ
Dongchao Lu, Shambhabi Chatterjee, Ke Xiao, Isabelle Riedel, Cheng-Kai Huang, Alessia Costa, Sarah Cushman, Dimyana Neufeldt, Laura Rode, Arne Schmidt, Malte Juchem, Julia Leonardy, Gwen Büchler, Jonas Blume, Olivia-Luise Gern, Ulrich Kalinke, Wilson Lek Wen Tan, Roger Foo, Aryan Vink, Linda W van Laake, Peter van der Meer, Christian Bär, Thomas Thum
doi : 10.1093/eurheartj/ehac337
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4496–4511
Cardiotoxicity leading to heart failure (HF) is a growing problem in many cancer survivors. As specific treatment strategies are not available, RNA discovery pipelines were employed and a new and powerful circular RNA (circRNA)-based therapy was developed for the treatment of doxorubicin-induced HF.
‘Circulating’ RNA-based therapies in Cardio-OncologyÂ
Carlo G Tocchetti, Alessandra Ghigo, Emilio Hirsch
doi : 10.1093/eurheartj/ehac407
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4512–4514
Pulmonary haemodynamics and pulmonary congestion: where are we now?Â
Nicole K Bart, Eugene Kotlyar, Anne M Keogh
doi : 10.1093/eurheartj/ehac499
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Page 4515
Pulmonary vascular reserve with exercise in heart failureÂ
Kazunori Omote, Barry A Borlaug
doi : 10.1093/eurheartj/ehac540
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4516–4517
Hypertrophic cardiomyopathy with extreme outflow tract obstructionÂ
Jeffrey B Geske, Elizabeth H Stephens, Joseph A Dearani
doi : 10.1093/eurheartj/ehac439
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Page 4518
Inflammatory infiltration of the cardiac conduction system in acute lymphocytic myocarditis
Juan Caro-Codón, Samuel López Muñoz, Esteban López-de-Sa
doi : 10.1093/eurheartj/ehac507
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Page 4519
Corrigendum to: 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
doi : 10.1093/eurheartj/ehac458
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Page 4468
Corrigendum to: Tigray Siege and its impact on cardiology services in Mekelle University Hospital: a call to action
doi : 10.1093/eurheartj/ehac529
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Page 4482
